1. Unambiguously identify a gene. 2. Identify the gene as a member of a family, which may give further information about gene function by reference to other family members 3. Identify the gene as the ortholog of a gene in another mammal (usually human) 4. Identify the gene as involved in a novel phenotype or trait Gene nomenclature should be registered at XXX (NISEED ? need to centralize all these infos).
Elements in a gene name
• Gene identifier: This is a stable identifier distinct from the internal DB ID and which is guaranteed to follow the gene throughout any changes that may be made to its structure. A possible syntax would be for a Ciona intestinalis coding gene (CG):
CiCG0004567. As these genes are generated automatically and independently for each species, there is no reason that CiCG0004567 and PmCG0004567 should be orthologous. Non coding genes should be identified according to the same syntax, but changing the middle characers: eg CitRNA0000085, CimiRNA0000054, …..
• Gene model name: Derived from the contig/scaffold on which they reside (e.g. in Ciona intestinalis KH2012:KH.C1.841). This name can change with time as novel information/analyses becomes available. Different species can have different syntaxes, reflecting the state of advancement of the assembly.
• Gene symbol: A short-form representation/abbreviation of the descriptive gene name, unique within the species. Usually 3-5 characters long, no more than 10. (e.g.
CYB5D1)
. Capital letters should be used. Gene symbols are italicized. The same symbols not italicized represent proteins. Orthologous ascidian genes have the same symbol.
Ascidian gene symbols should not be preceded by a mention of the species ('Ci', 'Pm', 'Hr') in current use, except when the distinction between orthologous genes in different ascidians needs to be made. In this case, a species prefix (e.g. Ci-) is added in front of the gene symbol.
The use of punctuation such as period and hyphens in gene symbols is discouraged, except under specific circumstances described below.
Ascidian symbols follow the following conventions. When a Ciona gene has a 1-to-1 mammalian ortholog, the mammalian symbol is adopted. In case of 1-to-many orthology relationships, the Ciona gene symbol reflects all human paralogs (e.g. When a Ciona gene shows preferential similarity to a mammalian gene without robust orthology association, it inherits the vertebrate symbol name followed by the suffixesrelated or -like (eg Ciona PROP-related is similar to mammalian Prop without being a confident ortholog).
Genes that belong to a given protein family, but show only limited similarity to nontunicate genes are considered tunicate-specific (TS). Their symbol is TS followed by the protein family name, followed by a number (e.g. TS-bHLH2 is a tunicate specific bHLH gene).
Genes with no protein sequence similarity to any gene outside tunicates do not receive a symbol or name, unless they have been functionally characterized (e. g. PEM for
Posterior End Mark).
• Gene name: A short sentence describing gene function or structure (e. g. cytochrome b5 domain containing 1).
• Gene synonyms: A gene can have several synonyms, which are names or symbols that have been applied to the gene at various times. These synonyms may be associated with the gene in databases and publications, but the established gene name and symbol should always be used as the primary identifier.
PSEUDOGENE NOMENCLATURE
Pseudogenes should be suffixed by -ps and a serial number if there are multiple pseudogenes.
If only one pseudogene copy of a particular gene has been found, it should be given the suffix -ps1.
Examples (find ascidian specific example) :
In mouse, phosphoglycerate kinase 1, pseudogenes 1 to 7, Pgk1-ps1 to Pgk1-ps7
In rat, calmodulin pseudogene 1, Calm-ps1
TRANSCRIPT NOMENCLATURE
No absolute identifier Name : GENE-SYMBOL.suffix, the suffix varies between gene model sets and species. It generally refers to the sequence accession ID or to the gene model set of reference (ex : otx.
KH.C4.84.v1.A.SL5-1)
è What it defined in other species (zebrafish) and could be interesting for us :
[Transcript variants that originate from the same gene are not normally given different gene symbols and names. However, variants from a single gene can be distinguished in publications by adding to the end of the full name a comma, "transcript variant", and a serial number; and by adding to the end of the symbol an underscore, "tv", and a serial number.
Examples:
Names -myosin VIa, transcript variant 1, myosin VIa, transcript variant 2,
Symbols -myo6a_tv1 myo6a_tv2]
TRANSCRIPTIONAL CIS-REGULATORY REGION NOMENCLATURE è Cis-regulatory region named in the tunicate community :
ci-"common gene name" "start of region/end of region e.g. ci-Otx -4037/+31
The problem of this nomenclature is that the sequence can regulate multiple genes + do we have to name an hypothetical cis-regulatory region that, after experiment, has no effect on gene expression ? We currently name these regions in ANISEED with the nearest gene.
In addition, the problem with the ANISEED nomenclature is the TSS definition and corresponding relatives coordinates (problem when assembly is updated).
è What it defined in other species (rat) and could be interesting for us :
Enhancers, promoters, and regulatory regions can influence multiple genes. In addition, they can be localized far away from the gene(s) that they affect. Thus, it is misleading to name them based on the gene for which regulation was first recognized.
Enhancers, promoters, and regulatory regions are to be symbolized as:
Rr# regulatory region # where # indicates the next number in the series
OPERONS (OR POLYCISTRONIC GENES) NOMENCLATURE
è Operons named in the tunicate community :
Ghost :
KHOP.807
è What it defined in other species (worm) and could be interesting for us :
-Groups of genes which are co-transcribed as operons are curated as Operon objects. -These have names formed from 'CEOP' followed by a value for the chromosome (1,2,3,4,5,X) and a unique 3 digit number like CEOP5460 and are manually curated using evidence from the SL2 trans-spliced leader sequence sites. è What it is defined in other species (mouse) and could be interesting for us :
The transgenic transposable elements are identified with a standard prefix Tg (for transgenic)
and Tn (for transposable element). The class of transposable element may be included in parentheses. The general format of the symbol is:
TgTn(transposon_class_abbreviation-vector)#Labcode
Example: TgTn(sb-T2/GT2/tTA)1Dla
The symbol consists of: beta-globin (Hbb2) minimal promoter driving hmgb1 fused to mCherry.
Example: Tg(actb2:stk11-mCherry) In this case the construct has a fusion protein of stk11
and mCherry under the control of the actb2 promoter.
In cases where a number of constructs are generated with differing sizes of promoter elements, these may be specified within the parentheses as follows:
Examples:
Tg(-3.5hhex:sptb-GFP) Tg(-6.0hhex:sptb-GFP)
These examples represent two constructs containing a fusion protein of spectrin beta (sptb) and GFP driven by an upstream enhancer containing either 3.5kb or 6.0kb 5' to the hhex gene.
However, in a number of cases, the changes within the construct may be too small to change the number of kbp. In this case, the constructs will be appended with a period and a number within the parentheses, referring to the element that has changed, instead of including further details in the name. Alternatively, if the .1, .2 nomenclature conflicts with a gene name, then a number may be placed at the beginning of the construct name. The numbering should start with a 1 and increment by one for each different construct. The details of construct differences will be available on the construct pages.
Example:
Tg(-1.7shha.1:GFP) For those situations where a construct utilizes enhancers or promoters from genes that regulate two or more genes, only one of the genes should be represented in the name such that the gene with the lowest number or gene closest to the promoter is listed.
Example: Tg(dlx1aIG:GFP) This construct utilizes intergenic (IG) regulatory elements of dlx1a and dlx2a to drive expression of GFP. In this case the lower numbered gene was listed in the name.
Example: Tg(zic4:Gal4TA4, UAS:mCherry) This construct utilizes an enhancer of the zic1 and zic4 genes to drive expression of Gal4TA4, with an additional cassette that has UAS driving mCherry expression. In this case the gene closest to the enhancer was listed in the name.
For those cases where a gene from a different species is used, the three letter abbreviation should be used (Homo sapien (Hsa), Mus musculus (Mmu), Salmo salar(Ssa)) followed by a period then the gene symbol. For human genes use the standard gene symbol conventions of all capital letters. For mouse and other species the first letter of the gene is capitalized.
Example: Tg(Hsa.FGF8:GFP) Here the promoter of the human FGF8 gene is driving expression of GFP.
Example: Tg(Ssa.Ndr2:GFP) Here the promoter of the salmon Ndr2 gene is driving expression of GFP.
Transgenic constructs using modified clones such as BACs and PACs should be named with the clone type inserted between the "Tg" and the "(" Example: GFP is inserted to replace the coding sequence of tal1 in the PAC with the GenBank# AL592495. The construct name would be TgPAC(tal1:GFP). The accession number of the clone must be included in the publication so that it can be associated with the construct. A link to the appropriate clone can be found on the construct page.
Enhancer, promoter, and gene-trap constructs may use Et, Pt, or Gt, all of which are considered types of transgenic constructs.
